At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 24 enrolled
Drug / intervention
Ocriplasmin +1 moredrug
Likely dose
Ocriplasmin 175µgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The MIC (Microplasmin In Children) Trial: A Randomized, Placebo-controlled, Double-masked, Clinical Trial of Intravitreal Microplasmin in Infants and Children Scheduled for Vitrectomy
In Brief
A Phase 2 clinical trial evaluating Ocriplasmin and Placebo for Vitrectomy. Completed, enrolled 24 participants across 1 site.
Detailed Summary
To evaluate the safety and preliminary efficacy of intravitreal microplasmin as an adjunct to conventional vitrectomy for the treatment of pediatric patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVitrectomy
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 2009
Enrollment StartFeb 2010
Primary CompletionDec 2011
Study CompletionApr 2012
TodayJul 2026
First PostedSep 29, 2009
Enrollment StartFeb 1, 2010
Primary CompletionDec 1, 2011
Study CompletionApr 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 16.8 years ago
Interventions
Ocriplasmindrug
175µg ocriplasmin intravitreal injection
Placebodrug
Placebo intravitreal injection